Type your tag names separated by a space and hit enter


CANCER PREVENTION IN HIGH-RISK GROUPS is a topic covered in the Harrison's Manual of Medicine.

To view the entire topic, please or purchase a subscription.

Harrison’s Manual of Medicine 19th edition provides 600+ internal medicine topics in a rapid-access format. Download Harrison’s App to iPhone, iPad, and Android smartphone and tablet. Explore these free sample topics:

Harrison’s Manual of Medicine - App + Web

-- The first section of this topic is shown below --


Risk factors include age, early menarche, nulliparity or late first pregnancy, high body-mass index, radiation exposure before age 30 years, hormone-replacement therapy (HRT), alcohol consumption, family history, presence of mutations in BRCA1 or BRCA2, and prior history of breast neoplasia. Models are able to predict a woman’s risk level (see www.cancer.gov/cancertopics/pdq/treatment/breast/healthprofessional#Section_627).


MRI scanning is a more effective screening tool than mammography in women with a familial breast cancer risk.


Women whose risk exceeds 1.66% in the next 5 years have been shown to have a 50% reduction in breast cancer from taking tamoxifen or raloxifene. Aromatase inhibitors have generally been superior to tamoxifen in the adjuvant treatment of hormone-sensitive breast cancer, and one of them (exemestane) reduces the risk of breast cancer by 65% in postmenopausal women at increased risk. Women with strong family histories should undergo testing for mutations in BRCA1 and BRCA2. Mutations in these genes carry a lifetime probability of >80% for developing breast cancer. Bilateral prophylactic mastectomy prevents at least 90% of these cancers but is a more radical prevention than the usual treatment for the disease. In addition, bilateral salpingo-oophorectomy reduces ovarian and fallopian tube cancer risk by about 96% in women with BRCA1 or BRCA2 mutations.

-- To view the remaining sections of this topic, please or purchase a subscription --


Loscalzo, Joseph, et al., editors. "CANCER PREVENTION in HIGH-RISK GROUPS." Harrison's Manual of Medicine, 19th ed., McGraw Hill Inc., 2017. harrisons.unboundmedicine.com/harrisons/view/Harrisons-Manual-of-Medicine/623503/all/CANCER_PREVENTION_IN_HIGH_RISK_GROUPS.
CANCER PREVENTION IN HIGH-RISK GROUPS. In: Loscalzo J, Jameson JL, Longo DL, et al, eds. Harrison's Manual of Medicine. 19th ed. McGraw Hill Inc.; 2017. https://harrisons.unboundmedicine.com/harrisons/view/Harrisons-Manual-of-Medicine/623503/all/CANCER_PREVENTION_IN_HIGH_RISK_GROUPS. Accessed April 23, 2019.
CANCER PREVENTION IN HIGH-RISK GROUPS. (2017). In Loscalzo, J., Jameson, J. L., Longo, D. L., Hauser, S. L., Fauci, A. S., & Kasper, D. L. (Eds.), Harrison's Manual of Medicine. Available from https://harrisons.unboundmedicine.com/harrisons/view/Harrisons-Manual-of-Medicine/623503/all/CANCER_PREVENTION_IN_HIGH_RISK_GROUPS
CANCER PREVENTION in HIGH-RISK GROUPS [Internet]. In: Loscalzo J, Jameson JL, Longo DL, Hauser SL, Fauci AS, Kasper DL, editors. Harrison's Manual of Medicine. McGraw Hill Inc.; 2017. [cited 2019 April 23]. Available from: https://harrisons.unboundmedicine.com/harrisons/view/Harrisons-Manual-of-Medicine/623503/all/CANCER_PREVENTION_IN_HIGH_RISK_GROUPS.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - CANCER PREVENTION IN HIGH-RISK GROUPS ID - 623503 ED - Loscalzo,Joseph, ED - Jameson,J Larry, ED - Longo,Dan L, ED - Hauser,Stephen L, ED - Fauci,Anthony S, ED - Kasper,Dennis L, BT - Harrison's Manual of Medicine UR - https://harrisons.unboundmedicine.com/harrisons/view/Harrisons-Manual-of-Medicine/623503/all/CANCER_PREVENTION_IN_HIGH_RISK_GROUPS PB - McGraw Hill Inc. ET - 19 DB - Harrison's Manual of Medicine DP - Unbound Medicine ER -